AR052155A1 - Compuestos organicos - Google Patents

Compuestos organicos

Info

Publication number
AR052155A1
AR052155A1 ARP050105195A ARP050105195A AR052155A1 AR 052155 A1 AR052155 A1 AR 052155A1 AR P050105195 A ARP050105195 A AR P050105195A AR P050105195 A ARP050105195 A AR P050105195A AR 052155 A1 AR052155 A1 AR 052155A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
water
insoluble
animal
human
Prior art date
Application number
ARP050105195A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR052155A1 publication Critical patent/AR052155A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Composicion que comprende un polímero termoplástico, un agente modificador de la velocidad y un agente biologicamente activo, util como implante de administracion de fármacos de liberacion lenta en el cuerpo de un ser humano o animal que se puede administrar en forma líquida en el cuerpo. Reivindicacion 1: Una composicion para formar un implante in situ dentro del cuerpo mediante la exposicion a los fluidos corporales, adecuada para una liberacion controlada del material bioactivo, que comprende un polímero termoplástico, biodegradable, farmacéuticamente aceptable, que es insoluble en un medio acuoso o en los fluidos corporales de un ser humano o animal, un solvente orgánico biodegradable, insoluble en agua o apenas soluble en agua, farmacéuticamente aceptable, un adyuvante biocompatible soluble en agua y farmacéuticamente aceptable y un agente biologicamente activo, caracterizado porque la cantidad en peso de dicho solvente es superior a la de dicho polímero termoplástico y porque el adyuvante se selecciona del grupo que comprende etanol, glicerol y glicerol formal.
ARP050105195A 2004-12-14 2005-12-12 Compuestos organicos AR052155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14

Publications (1)

Publication Number Publication Date
AR052155A1 true AR052155A1 (es) 2007-03-07

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105195A AR052155A1 (es) 2004-12-14 2005-12-12 Compuestos organicos

Country Status (16)

Country Link
JP (1) JP5372378B2 (es)
KR (1) KR101304160B1 (es)
CN (1) CN101056617B (es)
AR (1) AR052155A1 (es)
AT (1) ATE389386T1 (es)
AU (1) AU2005315823B2 (es)
BR (1) BRPI0519022A2 (es)
CA (1) CA2585779C (es)
DE (1) DE602005005522T2 (es)
ES (1) ES2301084T3 (es)
MX (1) MX2007007099A (es)
NZ (1) NZ554904A (es)
RU (1) RU2394558C2 (es)
TW (1) TWI369218B (es)
WO (1) WO2006063794A1 (es)
ZA (1) ZA200703506B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
HUE065367T2 (hu) * 2017-04-13 2024-05-28 Ceva Sante Animale Parazitafertõzések kezelésére használható injektálható anyag
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
US20260014227A1 (en) 2022-06-30 2026-01-15 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
JP2002512597A (ja) * 1996-12-20 2002-04-23 アルザ コーポレイション 注射可能な貯留槽ゲル組成物およびこの組成物の製造方法
ES2221363T3 (es) * 1998-02-23 2004-12-16 Massachusetts Institute Of Technology Polimeros biodegradables con memoria de forma.
CN1263435C (zh) * 1998-03-19 2006-07-12 麦克公司 控制释放生物活性物质的液态聚合物组合物
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
MXPA05004927A (es) * 2002-11-06 2005-09-08 Alza Corp Formulaciones de deposito de liberacion controlada.
WO2004081196A2 (en) * 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell- schedule dependent anticancer agents

Also Published As

Publication number Publication date
JP2008523131A (ja) 2008-07-03
AU2005315823A1 (en) 2006-06-22
DE602005005522T2 (de) 2009-04-16
KR20070092964A (ko) 2007-09-14
TWI369218B (en) 2012-08-01
CN101056617A (zh) 2007-10-17
KR101304160B1 (ko) 2013-09-04
ZA200703506B (en) 2008-09-25
RU2394558C2 (ru) 2010-07-20
ES2301084T3 (es) 2008-06-16
NZ554904A (en) 2009-11-27
JP5372378B2 (ja) 2013-12-18
BRPI0519022A2 (pt) 2008-12-23
WO2006063794A1 (en) 2006-06-22
CN101056617B (zh) 2012-07-11
DE602005005522D1 (de) 2008-04-30
MX2007007099A (es) 2007-06-22
AU2005315823B2 (en) 2009-06-04
TW200635616A (en) 2006-10-16
CA2585779A1 (en) 2006-06-22
CA2585779C (en) 2014-01-28
ATE389386T1 (de) 2008-04-15
RU2007126759A (ru) 2009-01-27

Similar Documents

Publication Publication Date Title
CA2273017C (fr) Dispositif d'administration locale de formulations solides ou semi-solides, formulations retard pour administration parenterale et procede de preparation
Almeida et al. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs
TWI377958B (en) In-situ gelling drug delivery system
ES2359973T3 (es) Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
RU2009111715A (ru) Устройство для локальной и/или региональной доставки с применением жидких составов терапевтически активных веществ
CA2468703A1 (en) Controlled release polymeric compositions of bone growth promoting compounds
ES2116308T5 (es) Procedimiento para la produccion de un dispositivo implantable a base de un material polimero, que contiene principios activos farmaceuticos.
JP2017522365A (ja) 薬物送達システム及び関連する使用方法
WO2006041942A3 (en) Ocular delivery of polymeric delivery formulations
NZ597621A (en) Sustained delivery formulations of risperidone compounds
JP2011093944A (ja) 生体分解性徐放性ドラッグデリバリーシステム
DK1660034T3 (da) Fremstilling af langtidsafgivende medikamentindretninger af polyurethanbaserede polymerer
DE60209446D1 (de) Medizinische Implantatvorrichtung , Einführgerät und Implantierungsverfahren für ein Wirkstoff und Zellen enthaltendes Implantat
RU2463079C2 (ru) Разделительные агенты для имплантируемого устройства и способы их применения
RU2015109296A (ru) Системы доставки лекарственного средства и способы лечения рака мочевого пузыря, включающие применение оксалиплатина
JP2009510048A (ja) ゲル化疎水性注入ポリマー組成物
HRP20221252T1 (hr) Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s gemcitabinom
AR118753A1 (es) Método de tratamiento de un niño con pubertad precoz central usando una composición de liberación prolongada
ES2301084T3 (es) Implante de formacion in situ para animales.
ES2433085T3 (es) Composición acuosa lubricante
Liu et al. Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model
AR053799A1 (es) Composiciones que contienen policonasol y teaflavina y sus usos farmaceuticos
TH79952A (th) สารอินทรีย์
JP2004534618A (ja) 再狭窄に対するビトロネクチン受容体アンタゴニストを有するステント

Legal Events

Date Code Title Description
FB Suspension of granting procedure